Optimizing Oncology Clinical Trials and Prospective Registries
CancerLinQ is developing a comprehensive solution to improve access to clinical trials for all patients with cancer, as well as increase recruitment and success rates for research studies and prospective registries. Using an integrated approach powered by one of the largest oncology practice networks in the world, TriaLinQ will facilitate clinical research for patients in CancerLinQ practices and provide sponsors access to a more diverse and representative patient population for observational and interventional trials and registries.
Powered by Automation
TriaLinQ is powered by the near real-time connection to the electronic health record (EHR) and secondary source systems of over 100 practices in the CancerLinQ network, providing the capability to automatically identify patients, use technology to enable patient recruitment, and pre-populate the electronic case report form (eCRF) with the real-world data collected as a part of routine clinical care.
Increasing Access
TriaLinQ is designed to support oncology prospective registries and clinical trials conducted in diverse patient populations, including those historically underrepresented in clinical investigations, across CancerLinQ’s growing network of community oncology practices and cancer centers.
Near Real-time Patient Identification and Streamlined Recruitment
Reduced Data Entry via Automated EHR Data Collection into the eCRF
Study Design Optimization
Trial Site Identification and Feasibility Analysis
Portfolio Optimization
Data Analytics and RWD for Synthetic Control Arms